Matrix Healthcare Solutions Adds MIA (IMP) to Portfolio of Licenses
Matrix Healthcare Solutions (MHS) has further complimented its expansive licensed capabilities with the addition of a Manufacturers Import Authorisation (MIA) for Investigational Medicinal Products (IMP). The stringent controls and high standards required for IMP management in clinical trials have a direct impact on product registration with regulatory and competent authorities around the world. The MIA (IMP) allows Matrix Healthcare Solutions to better serve its increasing global base of customers.
“The requirement for suppliers of clinical trials to have the ability to import and handle Investigational Medicinal Products has never been greater. The addition of an MIA (IMP) positions Matrix Healthcare Solutions uniquely with respect to our licensed capabilities & services available to the Pharmaceutical and Biotech companies that constitute our growing customer base.” – Daniel Low, Director
Clinical Trial Services from Matrix Healthcare Solutions
Matrix Healthcare Solutions is a specialist in clinical trial services, founded by industry experts with years of combined experience in key regions around the world. If you would like more information, simply contact a member of the Matrix Healthcare Solutions team today.